Subsidiary18 Sept 2026, 08:12 am
Zim Laboratories Incorporates Wholly Owned Subsidiary in Chile
AI Summary
Zim Laboratories Ltd has announced the incorporation of its wholly owned subsidiary, ZIM Laboratories SpA, in Santiago, Republic of Chile. This strategic move aims to expand and develop the company's pharmaceutical business within the LATAM region. The subsidiary was incorporated on September 9, 2026, with Zim Laboratories Ltd holding a 100% stake. The initial investment involved the subscription of 14,100 shares at a face value of CLP 1,000 each, with the consideration being cash.
Key Highlights
- Zim Laboratories Ltd established a wholly owned subsidiary in Chile.
- The subsidiary, ZIM Laboratories SpA, aims to expand pharmaceutical business in LATAM.
- The company holds a 100% stake in the newly incorporated entity.
- This marks a strategic expansion into the South American market.
Price Impact
More from ZIMLAB